Uremic pruritus

International Journal of Artificial Organs

Volumn 29, Issue 10, 2006, Pages 938-943

  Kosmadakis, George C ^a,b   Zerefos, N ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Dialysis; Pruritus; Uremia

Indexed keywords

BIOCOMPATIBILITY;

CHRONIC KIDNEY DISEASE; CHRONIC RENAL FAILURE; ETIOLOGIC FACTORS; LOCALISED; PRURITUS; PSYCHOLOGICAL DYSFUNCTION; RENAL TRANSPLANTATION; SKIN DISEASE; UREMIA; UREMIC PRURITUS;

DIALYSIS;

ACETYLCHOLINE; ALUMINUM; BETA 2 MICROGLOBULIN; BRADYKININ; CAPSAICIN; CETIRIZINE; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDORPHIN; ERYTHROPOIETIN; GABAPENTIN; HISTAMINE; HOMEOPATHIC AGENT; INTERLEUKIN 2; KALLIKREIN; LIDOCAINE; NALTREXONE; NICERGOLINE; NITROGEN; ONDANSETRON; OPIATE; PARATHYROID HORMONE; PLACEBO; SEROTONIN; SEROTONIN ANTAGONIST; SUBSTANCE P; TACROLIMUS; TROPISETRON; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUPUNCTURE; AROMATHERAPY; ARTICLE; BATH; BIOCOMPATIBILITY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DISEASE COURSE; EVIDENCE BASED MEDICINE; HEMODIALYSIS; HISTAMINE RELEASE; HUMAN; HYPOTHESIS; INFLAMMATION; KIDNEY TRANSPLANTATION; MEMBRANE FILTER; NERVE STIMULATION; NONMYELINATED NERVE; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PHYSICAL ACTIVITY; PREVALENCE; PRURITUS; REST; SLEEP; UREMIA;

EID: 33845864501     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602901003     Document Type: Article

References (73)

1. Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. Q J Med 2003; 96: 7-26.
2. Lugon JR. Uremic pruritus: a review. Hemodial Int 2005; 9: 416-7.
3. Murphy M, Carmichael AJ. Renal itch. Clin Exp Dermatol 2000; 25: 103-6.
4. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus-new perspectives and insights from recent trials. Nephrol Dial Transplant 2002; 17: 1558-63.
5. Fusaro M, Munaretto G, Spinello M, et al. Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient. Nephrol Dial Transplant 2004; 19: 1338-9.
6. Yosipovitch G, Zucker I, Boner G, et al. A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol 2001; 81: 108-11.
7. Stahle-Backdahl M, Wahegren CF, Hagernark O. Computerized recording of itch in patients on maintenance dialysis. Acta Derm Venereol 1989; 69: 410-4.
8. Szepietowski JO, Sikora M, Kusztal M, Salomon J, Magott M, Szepietowski T. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol 2002; 29: 621-7.
9. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690-4.
10. Zucker I, Yosipovitch G, David M, et al. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol 2003; 49: 842-6.
11. Subach RA, Marx MA. Evaluation of uremic pruritus at an outpatient hemodialysis unit. Ren Fail 2002; 24: 609-14.
12. Akhyani M, Ganji MR, Samadi N, et al. Pruritus in hemodialysis patients. BMC Dermatol 2005; 5: 7.
13. Morton CA, Lafferty M, Hau C, Henderson I, et al. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant 1996; 11: 2031-6.
14. Park TH, Park CH, Ha SK, et al. Dry skin (xerosis) in patients undergoing maintenance hemodialysis: the role of decreased sweating of the eccrine sweat gland. Nephrol Dial Transplant 1995; 10: 2269-73.
15. Szepietowski JC, Reich A, Schwartz RA. Uraemic xerosis. Nephrol Dial Transplant 2004; 19: 2709-12.
16. Ostlere LS, Taylor C, Baillod R, Wright S. Relationship between pruritus, transepidermal water loss, and biochemical markers of renal itch in haemodialysis patients. Nephrol Dial Transplant 1994; 9: 1302-4.
17. Carmichael AJ, McHugh MI, Martin AM. Renal itch as an indicator of poor outcome. Lancet 1991; 337:1225-6.
18. Balaskas EV, Grapsa E. Uremic pruritus is a poor prognostic factor of outcome. Pent Dial Int 1995; 15: 177.
19. Stahle-Backdahl M. Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1989; 145: 1-38.
20. Hiroshige K, Kabashima N, Takashugi M, et al. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 1995; 25: 413-9.
21. Masi CM, Cohen EP. Dialysis efficacy and itching in renal failure. Nephron 1992; 62: 257-61.
22. Zakrzewska-Pniewska B, Jedras M. Is prunitus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR). Neurophysiol Clin 2001; 31: 181-93.
23. Gunal AI, Ozalp G, Yoldas TK, et al. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 2004; 19: 3137-9.
24. Virga G, Visentin I, La Milia V, et al. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 2164-9.
25. Yago H, Fujita Y, Kaku H, et al. Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin: plasma levels of C3a, C5a, bradykinin and lipid peroxides. Nippon Jinzo Gakkai Shi 1989; 31: 1061-7.
26. Kimmel M, Alscher M, Dunst R, et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006; 21: 49-55.
27. Imazu LE, Tachibana T, Danno K, et al. Histamine-releasing factor (s) in sera of uraemic pruritus patients in a possible mechanism of UVB therapy. Arch Dermatol Res 1993; 285: 423-7.
28. Gilchrest BA, Rowe JW, Brown RS, et al. Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med 1977; 297: 136-8.
29. Garssen J, Vandebriel RJ, De Gruijl FR, et al. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology 1999; 97: 506-14.
30. Bosch-Krakenhaus R. Uraemic pruritus is not related to β-endorphin serum levels in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 231-2.
31. Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid system. J Am Med Assoc 1992; 268: 3359-62.
32. Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992; 102: 544-59.
33. Bergasa NV, Alling DW, Talbot TL, et al. Effects of naloxone infusion in patients with the pruritus of cholestasis: a double blind, randomized, controlled trial. Ann Intern Med 1995; 123: 161-7.
34. Peer G, Kivity S, Agami O, et al. Randomized crossover trial of naltrexone in uraemic pruritus Lancet 1996; 348: 1552-4.
35. Kivity S, Fireman E, Schwarz Y, Peer G, et al. The effect of naloxone on basophilic histamine release from dialyzed patients. Inflamm Res 1997; 46: 404-6.
36. Pauli-Magnus C, Mikus G, Alscher D, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 2000; 11: 514-9.
37. Togashi Y, Umeuchi H, Okano K, et al. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol 2002; 435923: 259-64.
38. Wilkstrom B, Gellert R, Ladeoged SD, et al. {kappa}-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studied. J Am Soc Nephrol 2005; 16: 3742-7.
39. Kuhlmann U. Uremic pruritus in patients on hemodialysis or continuous abdominal peritoneal dialysis. The role of plasma histamine and skin mast cells. Clin Nephrol 1990; 34: 136-141.
40. Weisshaar E, Dunker N, Domrose U, et al. Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy. Clin Nephrol 2003; 59: 124-9.
41. De Filippi C, Regazzini R, Piazza V, et al. Uraemic pruritus is not related to plasma histamine concentration. Clin Exp Dermatol 1995; 20: 294-6.
42. Stahle-Backdahl M. Pruritus in hemodialysis patients. Skin Pharmacol 1992; 5: 14-20.
43. Leong SO, Tan CC, Lye WC, et al. Dermal mast cell density and pruritus in end-stage renal failure. Ann Acad Med Singapore 1994; 23: 327-9.
44. Klein LR, Klein JB, Hanno R, et al. Cutaneous mast cell quantity in prurity and nonpruritic hemodialysis patients. Int J Dermatol 1988; 27: 557-9.
45. Rollino C, Goitre M, Piccoli G, et al. What is the role of sensitization in uremic pruritus? An allergiologic study. Nephron 1991; 57: 319-22.
46. Robertson KE, Mueller BA. Uremic pruritus. Am J Health Syst Pharm 1996; 53: 2159-70.
47. Cho YL, Liu HN, Huang TP, Tarng DC. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 1998; 38: 503-4.
48. Blanchley JD, Blankenship DM, Menter A, et al. Uremic pruritus and skin ion content. Am J Kidney Dis 1985; 5: 236-41.
49. Friga V, Linos A, Linos DA. Is aluminium toxicity responsible for uremic pruritus in chronic hemodialysis patients? Nephron 1997; 75: 48-53.
50. Tarng DC, Cho YL, Liu HN, et al. Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron 1996; 72: 617-22.
51. Kaku H, Fujita Y, Yago H, et al. Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin: plasma levels of substance P, somatostatin, IgE, PTH and histamine. Nippon Jinzo Gakkai Shi 1990; 32: 319-26.
52. Kuypers D, Claes K, Evenepoel P, Maes B, Vanrenterghem Y. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic therapy. Nephrol Dial Transplant 2004; 19: 1895-901.
53. Duque MI, Yosipovitch G, Fleiscer AB Jr, et al. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol 2005; 52: 519-21.
54. Balaskas EV, Uldall RP. Erythropoietin treatment does not improve uremic pruritus. Perit Dial Int 1992; 12: 330-1.
55. Masi CM, Cohen EP. Dialysis efficacy and itching in renal failure. Nephron 1992; 62: 257-61.
56. Okada K, Matsumoto K. Effect of skin care with an emollient containing high water content on mild uremic pruritus. Ther Apher Dial 2004; 8: 419-22.
57. Weisshaar E, Dunker N, Gollnick H. Topical capsaicin therapy in humans with hemodialysis-related pruritus. Neurosci Lett 2003; 345: 192-4.
58. Pauli-Magnus C, Mikus G, Alscher DM, et al. Nartrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 2000; 11: 514-9.
59. Balaskas EV, Bamihas GI, Karamouzis M, Voyagis C, Tourkantonis A. Histamine and serotonine in uremic pruritus: effect of ondasetron in CAPD-pruritic patients. Nephron 1998; 78: 395-402.
60. Albares MP, Betlloch I, Guijarro J, et al. Severe pruritus in a hemodialysed patient: dramatic improvement with granisetron. Br J Dermatol 2003; 148: 376-7.
61. Ashmore SD, Jones OH, Newstead CG, et al. Ondasetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis 2000; 35: 827-31.
62. Murphy M, Reaich D, Pai P, et al. A randomized, placebo-controlled, double-blind trial of ondasetron in renal itch. Br J Dermatol 2003; 148: 314-7.
63. Weisshaar E, Dunker N, Rohl FW, Gollnick H. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in hemodialysis patients. Exp Dermatol 2004; 13: 298-304.
64. Manenti L, Vaglio A, Constantine E, et al. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation. J Nephrol 2005; 18; 86-91.
65. De Marchi S, Cecchin E, Villalta D, et al. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 1992; 326: 969-74.
66. Che-Yi C, Wen CY, Min-Tsung K, Chiu-Ching H. Acupuncture in haemodialysis patients at the Quchi(LI11) acupoint for refractory uraemic pruritus. Nephrol Dial Transplant 2005; 20: 1912-5.
67. Cavalcanti AM, Rocha LM, Carillo R Jr, et al. Effects of homeopathic treatment on pruritus of haemodialysis patients: a randomized placebo-controlled double-blind trial. Homeopathy 2003; 92: 177-81.
68. Ro YJ, Ha HC, Kim CG, Yeom HA. The effects of aromatherapy on pruritus in patients undergoing hemodialysis. Dermatol Nurs 2002; 14: 231-4.
69. Bousquet J, Rivory JP, Maheut M, et al. Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis. J Allergy Olin Immunol 1989; 83: 825-8.
70. Giovannetti S, Bersotti G, Cupisti A, et al. Oral activated charcoal in patients with uremic pruritus. Nephron 1995; 70: 193-6.
71. Pederson JA, Matter BJ, Czerwinski AW, et al. Relief of idiopathic generalized pruritus in dialysis patients treated with activated oral charcoal. Ann Intern Med 1980; 93: 446-8.
72. Silva SR, Viana PC, Lugon NV, et al. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 1994; 67: 2011-2.
73. Blachley JD, Blankenship DM, Menter A, et al. Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis 1985; 5: 237-41.